MCLEAN, Va., April 26, 2018 -- Freddie Mac (OTCQB:FMCC) announced today that it issued its Monthly Volume Summary for March 2018, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities and other investments.
Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac and Freddie Mac’s blog FreddieMac.com/blog.
MEDIA CONTACT:
Christopher Spina
703-388-7031
[email protected]
INVESTOR CONTACT:
Laurie Garthune
571-382-4732


Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 



